Table 1 Demographic and clinical characteristics of patients
Patient No | Age [years] | Sex | BW [kg] | Primary disease | Conditioning pretreatment | Type of HSCT | RBC [× 104/μL] | Hct [%] | Hb [g/dL] | Alb [g/dL] | AST [U/L] | ALT [U/L] | T-bil [mg/dL] | Cre [mg/dL] |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
#1 | 4.3 | M | 13.3 | CGD | ATG, BU, Flu, TBI | rPBSCT | 332 | 28.9 | 9.9 | 3.8 | 43 | 121 | 0.3 | 0.18 |
#2 | 6.8 | F | 22.0 | BCP-ALL | Mel, TBI | CBT | 297 | 26.7 | 9.1 | 3.5 | 51 | 56 | 0.5 | 0.29 |
#3 | 9.6 | F | 35.2 | AML | CY, TBI | CBT | 290 | 26.2 | 8.9 | 3.3 | 76 | 89 | 0.8 | 0.24 |
#4 | 7.8 | M | 18.2 | AML | BU, Mel | rPBSCT | 312 | 32.5 | 10.7 | 2.6 | 113 | 150 | 0.5 | 0.23 |
#5 | 6.8 | M | 29.8 | MDS | ATG, Flu, Mel, TBI | uBMT | 348 | 33.1 | 11.5 | 3.6 | 51 | 109 | 1.2 | 0.32 |
#6 | 11.4 | F | 25.3 | T-ALL | CY, VP-16, TBI | uBMT | 287 | 28.2 | 9.6 | 2.4 | 96 | 95 | 3.5 | 0.24 |
#7 | 2.3 | F | 11.3 | AML | BU, CY | CBT | 315 | 33.2 | 10.9 | 3.2 | 27 | 47 | 0.4 | 0.13 |
#8 | 4.6 | M | 16.0 | BCP-ALL | CY, VP-16, TBI | CBT | 297 | 27.4 | 9.0 | 4.4 | 26 | 34 | 1.0 | 0.20 |
#9 | 2.6 | F | 9.8 | EBV-LPD | Ara-C, Flu, Mel, MIT, VP-16, PSL | CBT | 334 | 28.5 | 10.1 | 3.5 | 18 | 13 | 3.3 | 0.21 |
#10 | 0.7 | F | 7.3 | CAMT | ATG, Flu, Mel | CBT | 417 | 34.3 | 12.3 | 3.8 | 67 | 60 | 0.6 | 0.25 |
Median (range) | 5.7 (0.7–11.4) | 17.1 (7.3–35.2) | 314 (287–417) | 28.7 (26.2–34.3) | 10.0 (8.9–12.3) | 3.5 (2.4–4.4) | 51 (18–113) | 75 (13–150) | 0.7 (0.3–3.5) | 0.23 (0.13–0.32) |